• Je něco špatně v tomto záznamu ?

Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism

K. Smolková, E. Mikó, T. Kovács, A. Leguina-Ruzzi, A. Sipos, P. Bai

. 2020 ; 33 (13) : 966-997. [pub] 20200318

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21026432

Significance: Nuclear factor erythroid 2 (NFE2)-related factor 2 (NFE2L2, or NRF2) is a transcription factor predominantly affecting the expression of antioxidant genes. NRF2 plays a significant role in the control of redox balance, which is crucial in cancer cells. NRF2 activation regulates numerous cancer hallmarks, including metabolism, cancer stem cell characteristics, tumor aggressiveness, invasion, and metastasis formation. We review the molecular characteristics of the NRF2 pathway and discuss its interactions with the cancer hallmarks previously listed. Recent Advances: The noncanonical activation of NRF2 was recently discovered, and members of this pathway are involved in carcinogenesis. Further, cancer-related changes (e.g., metabolic flexibility) that support cancer progression were found to be redox- and NRF2 dependent. Critical Issues: NRF2 undergoes Janus-faced behavior in cancers. The pro- or antineoplastic effects of NRF2 are context dependent and essentially based on the specific molecular characteristics of the cancer in question. Therefore, systematic investigation of NRF2 signaling is necessary to clarify its role in cancer etiology. The biggest challenge in the NRF2 field is to determine which cancers can be targeted for better clinical outcomes. Further, large-scale genomic and transcriptomic studies are missing to correlate the clinical outcome with the activity of the NRF2 system. Future Directions: To exploit NRF2 in a clinical setting in the future, the druggable members of the NRF2 pathway should be identified. In addition, it will be important to study how the modulation of the NRF2 system interferes with cytostatic drugs and their combinations.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026432
003      
CZ-PrNML
005      
20211026132917.0
007      
ta
008      
211013s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1089/ars.2020.8024 $2 doi
035    __
$a (PubMed)31989830
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Smolková, Katarína $u Department of Mitochondrial Physiology, Institute of Physiology of the Czech Academy of Sciences (IPHYS CAS), Prague, Czech Republic
245    10
$a Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism / $c K. Smolková, E. Mikó, T. Kovács, A. Leguina-Ruzzi, A. Sipos, P. Bai
520    9_
$a Significance: Nuclear factor erythroid 2 (NFE2)-related factor 2 (NFE2L2, or NRF2) is a transcription factor predominantly affecting the expression of antioxidant genes. NRF2 plays a significant role in the control of redox balance, which is crucial in cancer cells. NRF2 activation regulates numerous cancer hallmarks, including metabolism, cancer stem cell characteristics, tumor aggressiveness, invasion, and metastasis formation. We review the molecular characteristics of the NRF2 pathway and discuss its interactions with the cancer hallmarks previously listed. Recent Advances: The noncanonical activation of NRF2 was recently discovered, and members of this pathway are involved in carcinogenesis. Further, cancer-related changes (e.g., metabolic flexibility) that support cancer progression were found to be redox- and NRF2 dependent. Critical Issues: NRF2 undergoes Janus-faced behavior in cancers. The pro- or antineoplastic effects of NRF2 are context dependent and essentially based on the specific molecular characteristics of the cancer in question. Therefore, systematic investigation of NRF2 signaling is necessary to clarify its role in cancer etiology. The biggest challenge in the NRF2 field is to determine which cancers can be targeted for better clinical outcomes. Further, large-scale genomic and transcriptomic studies are missing to correlate the clinical outcome with the activity of the NRF2 system. Future Directions: To exploit NRF2 in a clinical setting in the future, the druggable members of the NRF2 pathway should be identified. In addition, it will be important to study how the modulation of the NRF2 system interferes with cytostatic drugs and their combinations.
650    _2
$a zvířata $7 D000818
650    _2
$a antioxidancia $x metabolismus $7 D000975
650    _2
$a nádorové biomarkery $7 D014408
650    12
$a energetický metabolismus $7 D004734
650    _2
$a epigeneze genetická $7 D044127
650    _2
$a regulace genové exprese u nádorů $x účinky léků $7 D015972
650    _2
$a hormony $x metabolismus $7 D006728
650    _2
$a lidé $7 D006801
650    12
$a metabolické sítě a dráhy $7 D053858
650    _2
$a mikro RNA $x genetika $7 D035683
650    _2
$a mutace $7 D009154
650    _2
$a faktor 2 související s NF-E2 $x genetika $x metabolismus $7 D051267
650    _2
$a nádory $x etiologie $x metabolismus $x patologie $7 D009369
650    _2
$a nádorové kmenové buňky $x metabolismus $7 D014411
650    _2
$a oxidace-redukce $7 D010084
650    _2
$a oxidační stres $7 D018384
650    _2
$a signální transdukce $x účinky léků $7 D015398
650    _2
$a signální dráha UPR $7 D056811
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Mikó, Edit $u Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, Debrecen, Hungary $u MTA-DE Lendület Laboratory of Cellular Metabolism, Debrecen, Hungary
700    1_
$a Kovács, Tünde $u Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
700    1_
$a Leguina-Ruzzi, Alberto $u Department of Mitochondrial Physiology, Institute of Physiology of the Czech Academy of Sciences (IPHYS CAS), Prague, Czech Republic
700    1_
$a Sipos, Adrienn $u Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
700    1_
$a Bai, Péter $u Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, Debrecen, Hungary $u MTA-DE Lendület Laboratory of Cellular Metabolism, Debrecen, Hungary $u Faculty of Medicine, Research Center for Molecular Medicine, University of Debrecen, Debrecen, Hungary
773    0_
$w MED00006026 $t Antioxidants & redox signaling $x 1557-7716 $g Roč. 33, č. 13 (2020), s. 966-997
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31989830 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026132923 $b ABA008
999    __
$a ok $b bmc $g 1715220 $s 1146939
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 33 $c 13 $d 966-997 $e 20200318 $i 1557-7716 $m Antioxidants & redox signaling $n Antioxid Redox Signal $x MED00006026
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Možnosti archivace